International Murex enters diagnostic monitoring market via Innogenetics deal.
This article was originally published in The Gray Sheet
Executive Summary
INTERNATIONAL MUREX TO MARKET INNOGENETICS GENE PROBE MONITORING TESTS under an exclusive agreement announced Feb. 7. The deal, which represents International Murex Technologies' first foray into the diagnostic monitoring market, gives the firm worldwide marketing rights to Ghent, Belgium-based Innogenetics' existing and future gene probe tests, Murex says.